Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting on Wegovy is one of the most commonly reported side effects, and it tends to peak in the first few weeks or after a dose step-up. The good news is that for most people it eases considerably once the body adjusts — and there are practical steps that genuinely reduce how often it happens. These are prescription-only medicines requiring clinical assessment; a prescriber decides suitability and guides you through side effects as part of ongoing care. This page covers what works, what the evidence says, and when vomiting is a signal to seek medical help rather than wait it out.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people conclude that vomiting is a sign something has gone wrong, or that their body is rejecting treatment. That framing leads many to stop prematurely. The reality is almost the opposite: the nausea and vomiting associated with semaglutide are a direct consequence of the drug doing what it is supposed to do, slowing how quickly the stomach empties and signalling fullness to the brain. The NHS medicines page for semaglutide lists vomiting as a common side effect, meaning it affects more than one in ten people, particularly early in treatment or after moving to a higher dose.
This does not mean the experience is trivial or that you just have to endure it. It means the cause is understood, and targeted adjustments (in how you eat, when you eat, and how you manage the days around a dose) can make a real difference. Stopping treatment abruptly without speaking to your prescriber is rarely the right answer. The adjustment period is real, but it does pass.
Our prescribers discuss Wegovy's full side-effect profile, including strategies for managing vomiting, as part of every consultation and ongoing review. No one should be quietly struggling through it alone.
The most consistently useful change is eating less at each sitting. Wegovy slows gastric emptying, so a portion that felt normal before treatment may now sit uncomfortably in the stomach for far longer. Smaller meals, eaten more slowly, reduce the pressure that triggers vomiting. Eating three or four modest portions across the day tends to work better than two larger ones.
Certain foods make things noticeably worse. High-fat meals, very sweet foods, heavily spiced dishes, and anything particularly rich are reliable triggers for nausea and vomiting in people on semaglutide. Bland, protein-forward foods (eggs, plain chicken, fish, lentils) are easier to tolerate. Keeping well hydrated with water or diluted drinks helps, too, particularly between rather than during meals.
Timing matters as well. Some people find vomiting worse if they eat within an hour of injecting. Many find it helpful to take their weekly injection in the evening, so the peak effect passes overnight. There is no single rule here; your prescriber can help you find a pattern that suits your routine. The pen itself lives in the fridge, so a simple habit of injecting on the same evening each week, after dinner rather than before it, is worth trying if mornings are difficult.
For a broader picture of how nausea and other gastrointestinal symptoms tend to progress across the first months, the Wegovy side-effects timeline is worth reading alongside this page.
Most vomiting on Wegovy is uncomfortable but not dangerous. There are situations, though, where it becomes a clinical concern and needs prompt attention.
The first is dehydration. If vomiting is frequent enough that you cannot keep fluids down for more than a few hours, kidney function can be affected. Signs of dehydration include a dry mouth, dark urine, dizziness, and feeling faint on standing. This warrants a call to 111 or a same-day GP appointment rather than waiting to see if it resolves.
The second is severe abdominal pain. In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a known, though infrequent, serious side effect of GLP-1 medicines including semaglutide. The characteristic warning sign is intense, persistent stomach pain that may spread toward the back, with or without vomiting. If that description fits what you are experiencing, do not wait, seek urgent medical care. You can find the MHRA's latest safety communications via the Drug Safety Update index on GOV.UK.
If vomiting is bringing up yellow or green fluid (bile) rather than food or stomach acid, or if you notice blood in what you bring up, those are also reasons to contact a clinician without delay. More detail on that specific pattern is covered in our guide to vomiting bile on Wegovy.
Finally, if vomiting is severe enough that you cannot take other regular medicines, tell your prescriber. Absorption of oral drugs, including the contraceptive pill, may be affected when Wegovy slows gastric emptying, another reason not to manage side effects in isolation.
Vomiting that is genuinely disrupting daily life is a legitimate clinical reason to discuss slowing your titration schedule. Progressing to a higher dose is not mandatory if the current dose is causing significant side effects; many people benefit from spending longer at a lower dose before moving up. That decision belongs to your prescriber, not to a feeling of obligation to follow the standard schedule.
If you are experiencing vomiting from semaglutide that is not responding to dietary adjustments, or if it is affecting your ability to work or care for yourself, mention it at your next review. Anti-nausea medication is sometimes appropriate as a short-term measure, again subject to clinical assessment.
For anyone weighing up whether vomiting risk changes the overall picture of Wegovy for them, our clinical team page gives a sense of how prescribers at nume approach weight-management consultations. Side-effect management is part of the service, not a separate conversation. You can also read more about nausea and vomiting on Wegovy together, since the two are closely related and the strategies overlap considerably.
If you are still in the process of deciding whether Wegovy suits you, the free consultation with our prescribers is the right starting point. Eligibility, side effects and your individual medical history are all reviewed before any prescription is issued. Our dedicated page on Wegovy vomiting also brings together the practical guidance in one place, which many people find useful to share with a family member or carer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.